Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Poractant alfa

Known as: fractions phospholipid, poractant, poractant alfa [Chemical/Ingredient] 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Background:CHF5633 is a new generation synthetic surfactant containing both SP-B and SP-C analogues developed for the treatment… Expand
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
Highly Cited
2013
Highly Cited
2013
BACKGROUND: The primary aim of this randomized study was to describe the feasibility of early administration of surfactant via a… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
2013
2013
Objective:The objective of this study is to compare all-cause in-hospital mortality in preterm infants with respiratory distress… Expand
  • table 1
  • table 1
  • figure 1
  • figure 2
2013
2013
OBJECTIVE To compare effectiveness of 3 surfactant preparations (beractant, calfactant, and poractant alfa) in premature infants… Expand
2012
2012
We prospectively evaluated the differences in clinical responses and short-term outcomes in preterm infants with respiratory… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
2010
2010
Objective:Comparison of the differences between availability of animal-derived surfactant preparations used to treat premature… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Highly Cited
2005
Highly Cited
2005
Background. Available therapeutic surfactants are either animal-derived or non–protein-containing synthetic products. Animal… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Highly Cited
2005
Highly Cited
2005
AIM To compare the effects of beractant and poractant in neonatal respiratory distress syndrome (RDS). METHODS Infants with RDS… Expand
Highly Cited
2004
Highly Cited
2004
We compared the onset of clinical response and safety of two surfactants, poractant alfa (Curosurf, Chiesi Pharmaceuticals, Parma… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Highly Cited
2000
Highly Cited
2000
BACKGROUND Exogenous surfactant preparations vary in their constitution and biophysical properties. Synthetic and animal-derived… Expand